CID 797718

CAS No. 370586-05-3

CID 797718( CID 797718 | CID-797718 | CID797718 )

Catalog No. M14274 CAS No. 370586-05-3

CID-797718 is a compound with unknown details.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 155 In Stock
5MG 141 In Stock
10MG 212 In Stock
25MG 357 In Stock
50MG 498 In Stock
100MG 686 In Stock
200MG 923 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CID 797718
  • Note
    Research use only, not for human use.
  • Brief Description
    CID-797718 is a compound with unknown details.
  • Description
    CID-797718 is a compound with unknown details.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CID 797718 | CID-797718 | CID797718
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Other Indications
  • Indication
    ——

Chemical Information

  • CAS Number
    370586-05-3
  • Formula Weight
    217.22
  • Molecular Formula
    C12H11NO3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    O=C(C1=C2CCCN1)OC3=C2C=C(O)C=C3
  • Chemical Name
    9-Hydroxy-1,2,3,4-tetrahydro-5H-chromeno[3,4-b]pyridin-5-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Rhein-8-glucoside ca...

    Rhein-8-O-beta-D-glucopyranoside(Rhein-8-glucoside calcium salt) shows moderate bioactivity against human Protein Tyrosine Phosphatase 1B (hPTP1B) in vitro.

  • Pueraria glycoside

    Pueraria glycoside shows marked peroxynitrite.

  • 3-Hydroxybakuchiol

    3-Hydroxybakuchiol exerts cytotoxic and anti-proliferative effects on the TA3/Ha mouse mammary adenocarcinoma cell line and induces a decrease in the mitochondrial transmembrane potential, the activation of caspase-3, the opening of the mitochondrial permeability transport pore (MPTP) and nuclear DNA fragmentation.3-Hydroxybakuchiol has antitumor activity resulting from interactions with the ETC, a system that is already deficient in cancer cells.